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ABSTRACT
JAMES MITCHUM: Calmodulin/Ca2+-Dependent Protein Kinase II Activity and
Expression in the Aged Mouse Hippocampus
(Under the direction of Nicole Ashpole)

CaM Kinase II (Ca2+/calmodulin-dependent protein kinase II) is a
serine/threonine-specific protein kinase enzyme that acts as a critical regulator of learning
and memory. It has previously been shown that the inability of CaMKII to maintain
activation is connected to memory deficits within the aging brain. While the connection
between CaMKII dysfunction and learning and memory impairments is well established,
little is known about the changes that cause CaMKII dysfunction. Our research set out to
investigate if CaMKII is altered during the process of aging. Specifically, we looked at
activity, regulation, and stability by conducting experiments to quantify CaMKII levels of
activity and protein expression in both young and aged mouse hippocampi. We
hypothesized that when compared to young mouse hippocampi, aged mouse hippocampi
would have lower levels of total CaMKII activity, lower levels of phosphorylated
CaMKII expression, and increased levels of CaMKII inhibitor expression. The impact of
our research lies in the illumination of the mechanisms causing CaMKII dysfunction. By
casting light on the process of CaMKII dysfunction, we will help future researchers to
establish a possible therapeutic target in the fight against learning and memory
impairments.
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BACKGROUND
Ca2+ Signaling in the Brain
The calcium cation Ca2+ is among the most important secondary messengers in
cellular signaling, influencing almost every process within the cell. Ca2+ signaling is of
particular importance in both neuronal growth and survival. Although Ca2+ is vital to the
livelihood of the cell, it also has the ability to do great cellular harm. Because of the fact
that the cation is highly reactive and prolonged exposure to high levels of Ca2+ can be
toxic to the cell. When intracellular Ca2+ levels become too high, both mitochondrial
depolarization and over-activation of downstream signaling pathways can occur. In order
to avoid the toxic side effects of high levels of Ca2+ the cell must use pumps, channels,
and proteins to preserve low cellular concentrations of the cation. A family of proteins
that play an important role in Ca2+ mediation is the calmodulin (CaM) kinase proteins.

The CaM Kinase Family and the Structure of CaMKII
The CaM kinases are a group of serine/threonine protein kinases, which are activated
by calcium-bound calmodulin and phosphorylate a serine or a threonine residue in its
substrate P-site. The substrate P-site is the target site of phosphorylation. While the CaM
kinases all share this defining targeting motif, they each undergo different mechanisms of
regulation. Because of the variation in regulation across the family, CaM kinases play
roles in a plethora of cellular functions. In this study, we will focus on the neuronal
functions of CaMKII. Ca2+/calmodulin (CaM)-dependent protein kinase II (CaMKII) is a
mediator of Ca2+ signaling that has the ability to phosphorylate a variety of substrates in
order to coordinate and regulate cellular functions related to Ca2+ signaling (Ashpole
7

2011). The mediation functionality of CaMKII arises from the enzyme’s unique structure.
CaMKII has the form of a multimeric holoenzyme with a C-terminal association domain
creating a central hub and N-terminal kinase domains protruding outward. In the space
between these two domains, CaMKII has a Ca2+/CaM-binding autoregulatory region as
well as a variable region in which splicing can occur (Coultrap 2011). Because of
CaMKII’s multimeric structure and autoregulatory domain, it is able to play an active
role in the location, timing, and sensitivity of its action. CaMKII can: (1) be activated in a
manner dependent on Ca2+ concentration, (2) achieve independence from its initial
Ca2+/CaM activators, and (3) function as a molecular switch, which is a function vital to
certain types of learning and memory (Hudmon and Schulman 2002). The four CaMKII
isoforms are α, β, γ, and δ. All CaMKII isoforms have a catalytic domain, an
autoregulatory domain, a variable region, as well as a self-association domain. There are
binding sites for adenosine triphosphate (ATP) and other substrate proteins inside the
catalytic domain. Moreover, it is at this domain that a phosphate is transferred from ATP
onto a Ser or Thr substrate residue (Hudmon and Schulman 2002). When
phosphorylation occurs at Thr-286, CaMKII is constitutively activated due to the fact that
the autoregulatory domain is blocked and can no longer bind to the p-site. When this
circumstance occurs, CaMKII remains activated, even when Ca2+ and calmodulin are
absent (Yang 1999). The variable and self-associative domains are responsible for the
sensitivity of CaMKII to Ca2+ and calmodulin. The activation state of the enzyme will be
dictated by CaMKII’s level of sensitivity. Initially, the CaMKII is in an active state;
autophosphorylation is not possible at this time due to the lack of Ca2+ or calmodulin,
which are necessary to facilitate binding to neighboring subunits. As Ca2+ and calmodulin
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levels increase, autophosphorylation takes place resulting in persistent activation of
CaMKII for a brief period. The autophosphorylation of CaMKII will be discussed later in
detail. When dephosphorylation of Thr-286 occurs, CaMKII becomes inactivated. It is
the features of the variable and self-association domains that determine the identity of the
different CaMKII isoforms. It is important to note that under ischemic conditions,
CaMKII forms extra-synaptic clusters by way of the CaMKII holoenzyme selfaggregation mechanism (Dosemeci 2000; Tao-Cheng 2002; Hudmon 2005; Vest 2009).

Prevalence of CaMKII in Neurons
While CaMKII is found in the majority of tissues, it has particularly high
concentration within neurons. The two splice variants which make up the majority of
isoforms in neurons are α (50 kDa) and β (60 kDa) (Bayer 1998; Schulman 1978).
CaMKIIβ functions as a targeting or docking module, and CaMKIIα is crucial to
neuronal plasticity, spatial memory, and hippocampal long-term potentiation (LTP). The
γ and δ isoforms are highly expressed in astrocytes and are also expressed throughout the
body (Tobimatsu and Fujisawa 1989; Takeuchi 2000)

Functionality of α-CaMKII in Neuronal Plasticity and Spatial Memory
α-CaMKII is expressed exclusively in glutamatergic neurons: glutamatergic neurons
produce glutamate, which is among the most common excitatory neurotransmitters in the
central nervous system (Institute of Medicine (US) Forum on Neuroscience and Nervous
System Disorders 1970). In the hippocampus, CaMKII is not localized in the nucleus.
Thus, α-CaMKII is not directly involved in gene transcription in the hippocampus (Giese
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2013). It has been established that α-CaMKII plays a part in hippocampal neuronal
plasticity; for example, it has been shown that CaMKII inhibition induces neuronal
apoptosis (Ashpole 2012). Studies have also shown that α-CaMKII mutations impair
spatial learning in mice (Silva 1992; Ohno 2006). Moreover, α-CaMKIIThr-286A+/- mutant
mice exhibit impaired new learning induced by extinction training, while extinction
related unlearning was unaffected (Kimura 2008).

Functionality of α-CaMKII in Long-Term Potentiation
Long-term potentiation (LTP) and long-term depression (LTD) are synaptic processes
that take place over an extended period during the learning process. LTP and LTD work
in opposition to each other: LTP functions to strengthen synapses, and LTD works to
decrease synaptic strength. The length of time in which LTP takes place makes it a likely
mechanism of memory storage. When LTP induction occurs, calcium is able to enter the
cell. Once Ca2+ enters, CaMKII is activated. Upon activation CaMKII translocates to the
synapse, where it binds to N–methyl-D-aspartate (NMDA) receptors and brings about
potentiation via the phosphorylation of glutamate receptor subunits (Lisman 2012).
NMDA receptors are a type of ionotropic glutamate receptor; the flux of Ca2+ through
NMDA receptors is believed to be critical in synaptic plasticity. Likewise, When CaMKII
is inhibited, memory formation is substantially impaired (Giese 2013; Lisman 2002;
Elgersma 2004; Irvine 2006; Wayman 2008; Lucchesi 2011; Coultrap and Bayer 2012;
Ashpole 2012). Long-term depression (LTD) works in opposition to LTP in order to
diminish synaptic signaling for an extended period of time.
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Autophosphorylation of α-CaMKII
The role of CaMKII in transducing synaptic activity as a means to cause change in
synaptic strength and facilitate learning and memory is dependent upon the
autophosphorylation of Thr-286 (Hudmon and Schulman 2002). Upon
autophosphorylation at Thr-286, CaMKII becomes autonomous, meaning that it acts
independently from Ca2+ stimulation. It is the autonomy achieved by autophosphorylated
CaMKII that allows the kinase to control the induction and maintenance of the synaptic
plasticity underlying learning and memory (Coultrap 2012). Likewise, CaMKII
autonomy is known to be of importance in neuronal plasticity as well (Ashpole, Song,
Brustovetsky, Engleman, Brustovetsky, Cummins, & Hudmon 2012). It is important to
note that Thr-286 autophosphorylation has a function in the mediation of LTP induction
and memory formation rather than LTP maintenance and memory storage as evidenced
by previous inhibitor studies (Coultrap 2012). Introduction of an α-CaMKIIT286A-129B6F2
point mutation, which blocks Thr-286 autophosphorylation, results in severe impairments
to hippocampus-dependent memory formation: this result suggests that
autophosphorylation is a process of critical importance (Giese 1998; Need and Giese
2003; Irvine 2005 and 2011).

Dysfunction of CaMKII and Its Connection to Dementia
The progressive loss of synaptic elements preceding neuronal death has been
correlated with the advancement of cognitive decline in humans and rodents alike (Terry
1991; Moolman 2004). The hippocampal and cortical regions show the most loss of these
features in patients exhibiting symptoms across the cognitive dementia spectrum (Ghosh
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2015). While the precise mechanism by which synaptic dysfunction occurs in the aging
brain remains unclear, it has previously been shown that Aβ oligomers are able to bind to
synaptic sites and reduce LTP while also promoting LTD (Lambert 1998; Walsh 2002;
Lacor 2004; Shankar 2008; Li 2009). It is thought that Aβ oligomers may target post
synaptic elements (Marcello 2008) such as CaMKII among other signaling pathways.
Building upon this thought, it has been shown that Ca2+ concentration homeostasis is
dysregulated in Alzheimer’s disease (LaFerla 2002; Bezprozvanny 2008). Furthermore,
Aβ oligomers can intrude on Ca2+ signaling pathways and impair cognitive function
(Mattson 1991; Demuro 2010). Because of its important role in post-synaptic LTP
induction, CaMKII is likely a binding target for Aβ oligomers. It has been shown that
CaMKII is dysfunctional in Alzheimer’s disease hippocampi (Ghosh 2015). Likewise, it
has been shown that subcellular localization of α-CaMKII autophosphorylation is altered
in Alzheimer’s diseased brains (Reese 2011). It has been established that treating
hippocampal neurons with Aβ oligomers impairs CaMKIIα activation (Wang 2013;
Townsend 2007). Furthermore, redistribution of phosphorylated Thr-286 in CaMKIIα
could act as a contributor to cognitive impairment in Alzheimer’s disease.

Unknown Mechanism of CaMKII Dysfunction in the Naturally Aging Brain
Although it has previously been shown that the inability of CaMKII to maintain
activation is connected to memory deficits within the diseased brain, very little is known
about the mechanism of CaMKII dysfunction in the naturally aging brain. In this study,
our central aim was to determine if CaMKII activity, regulation, and or stability are
altered during the natural process of aging in the wild type mouse hippocampus. In order
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to accomplish our aim, experiments were done to quantify activity, gene expression, and
protein expression in both young and aged wild-type mouse hippocampal supernatant and
aggregate samples.

METHODS

Figure 1: Methodology Flow Chart: first, the hippocampi of young and aged mice were
isolated. The hippocampal samples were then split evenly into two groups. The first
group of samples were lysed and centrifuged prior to being utilized in protein
quantification and western blot analysis. The second group of samples underwent qPCR.
Activity Assays were also performed

Animals and Hippocampus Isolation
The animals used in this study were young and aged wild type C57Bl6 mice
purchased from Jackson Laboratories. The mice were aged in house and given access to
food and water ad libidum. All procedures were approved by the Institutional Animal
Care and Use Committee. The young mice were between 3 and 4 months old at the time
of euthanasia, and the aged mice were 24 months old at the time of euthanasia. It is
important to note that the aged mice used in this study had previously exhibited impaired
13

learning and memory in behavioral studies. In accordance with our IACUC approved
standard operating procedures, mice were euthanized by rapid decapitation, and the brain
and dorsal hippocampus was dissected out.

Sample and Buffer Preparation
In order to prepare the samples, lysis buffer was made using the following recipe:
50 mM HEPES buffer (pH 7.4), 4 mM EGTA buffer, 10 mM EDTA buffer, 15 mM
Na4P2O7-10H2O, 100 mM β-glycerophosphate, 25 mM NaF, and protease inhibitor were
combined in order to yield lysis buffer. After lysis buffer was added to the tissue samples,
the pellets were sonicated for 3 sec. Next, 200 μl of RIPA buffer was added to each
supernatant sample; then the supernatant samples were centrifuged for 30 min at 1200 xg.
The RIPA buffer was made using the following recipe: 50 mM Tris-Cl (pH 7.4), 150 mM
NaCl, 1% NP-40, ), 25% Na-Deoxycholate, 1 mM PMSF, 1X Roche complete mini
protease inhibitor cocktail, and 1X Pierce phosphatase inhibitor cocktail. At this point,
samples were either used in activity assays or underwent protein quantification followed
by western blot analysis.

Protein Quantification
A detergent compatible protein assay (DC protein assay) was performed on both
resuspended pellet and supernatant samples using the microplate assay protocol from the
BioRad DC Protein Assay instruction manual. 20 μl of Reagent S was added to 1 ml of
Reagent A to make Reagent A’. Serial solutions of BSA standard were used to establish a
BSA concentration curve. 1:10 dilutions of each sample were made. On a clean dry
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microtiter plate, 5 μl of standards as well as diluted and undiluted samples were added. 25
μl of Reagent A’ was added to each well. Then 200 μl of reagent B was added into each
well. The microplate was incubated for 15 min and then absorbance was read at 750 nm.
In order to prepare the protein samples for gel electrophoresis, the volume of protein
sample necessary to yield 10 μg of protein was calculated. Then specific amounts of
ddH2O and 4X LDS buffer were added to each protein sample. The LDS buffer was made
by adding 20 μl of BME to 1 ml of 4X LDS. The mixed samples were then heated for 5
min at 95 ⁰C, centrifuged, and cooled. The mixed samples were then loaded on to the gel.

SDS-PAGE Protein Electrophoresis
The precast gel cassette was prepared by removing the comb and removing the strip
of tape at the bottom of the cassette. Next, the gel was placed inside the electrophoresis
cassette holder, and the well and the front reservoirs were filled with 1X MOPS running
buffer. At this point two important checks were done: it was confirmed that the lip of the
gel faced the buffer and it was made sure that there were no leaks from the assembly.
Also, the wells were rinsed 3 times with 1X MOPS running buffer before the samples
were loaded. Next, the samples were slowly added into their corresponding wells as was
the appropriate molecular weight marker. The electrodes were connected and the gel was
run at 80 V until the dye was fully integrated into the gel, which usually took 20 min. The
voltage was increased to 120 V and the gel ran until loading dye was in the bottom fifth
of the gel: this step usually took 90 min. The protein samples were now ready to be
transferred from gel to nitrocellulose membranes. Having presoaked all necessary
membranes, pads, and filter paper in ice cold 1X NuPAGE transfer buffer, the sandwich

15

assembly was made. Next the assembly was secured in the transfer electrophoresis
holder, and the outside system was filled with ice cold NuPAGE transfer buffer. The
system was run at 30 V for a minimum of 1 hr. Once transfer was completed, the
membranes were soaked in 5% BSA blocking buffer and were shaken for 1 hr. The
membranes were rinsed 3 times for 5 min with TBST. Next, the membranes were
incubated with the primary antibody. The primary antibodies used in this study were
purchased from Cell Signaling Technology. They were CaMKII-Alpha mouse
monoclonal antibody, P-CaMKII (T286) rabbit monoclonal antibody, CaMKII Nβ mouse
monoclonal antibody, and GAPDH rabbit monoclonal antibody. The primary antibody
dilutions used in this study ranged in volume (7-10 ml per gel) and concentration (1:1000
– 1:5000). The gels were incubated with the diluted primary antibody and TBST on a
shaker for 1 to 2 hrs at room temperature or overnight at 4 ⁰C. After having been
incubated with the primary antibody, the gel was now ready to be incubated with the
secondary antibody. The secondary antibodies used in this study were purchased from
Invitrogen and ThermoScience. They were ThermoScience goat anti-mouse IgG (H+L)
secondary antibody (α-CaMKII, CaMKII Nβ, GAPDH) and Invitrogen Goat antiRabbit
IgG (H+L) cross absorbed secondary antibody (P-CaMKII), The secondary antibody
dilutions used in this study ranged in volume (7-10 ml per gel) and concentration
(1:10000-1:20000). The gels were incubated in darkness with the diluted secondary
antibody in TBST buffer for 1 hr at room temperature. After 1 hr, the secondary antibody
was discarded and the membranes were washed quickly 3 times in TBST and then were
washed 3 times for 5 min in TBST. Each of the secondary antibodies used in our study
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were fluorescently tagged secondary antibodies. The antibodies were visualized using
Licor Odyssey scanners in the labs of Dr. Jason Paris and Dr. David Pasco.

CaMKII Activity Assay
The catalytic activity of CaMKII in lysed hippocampi was evaluated by measuring
phosphorylation of the CaMKII autoregulatory domain autocamtide-2 (AC2). As
mentioned previously, neuronal cultures were lysed in lysis buffer containing 50 mM
HEPES, pH 7.4, 4 mM EGTA, 10 mM EDTA, 15 mM Na4P2O7-10H2O, 100 mM βglycerophosphate, 25 mM NaF, 1% Triton X-100, and protease inhibitor mixture,
sonicated, and incubated with 50 mM HEPES, pH 7.4, 100 mM NaCl, 10 mM MgCl2,
100 M ATP, 2 mM CaCl2, 5 M CaM, 50 M AC2 (KKALRRQETVDAL), and [γ32P]ATP (3 μCi per reaction) for 3 min at 30 °C. The linear range of the reaction
extended from 30 sec to 4 min. Protein levels were assessed, and activity at 1 min was
normalized to total protein using DC protein assay kit (Bio-Rad).

Real Time Quantitative Polymerase Chain Reaction
Polymerase Chain Reaction was utilized in order to amplify gene expression of αCaMKII (Mm00437967_m1 Camk2a FAM-MGB / 20X), β-CaMKII (Mm00499266_m1
Camk2d FAM-MGB / 20X), γ-CaMKII (Mm00618054_m1 Camk2g FAM-MGB / 20X),
δ-CaMKII (Mm00432284_m1 Camk2b FAM-MGB / 20X), and the housekeeping genes
Hypoxanthine Guanine Phosphoribosyltransferase (HPRT) (Mm03024075_m1 HPRT
FAM-MGB / 20X) and GAPDH (Mm99999915_g1 GAPDH FAM-MGB / 20X) in
young and aged mouse hippocampal tissue samples. The Qiagen RNeasy Mini Kit was
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used in order to isolate the RNA. And the ThermoFisher High-Capacity RNA to cDNA
Kit was used to reverse transcribe the cDNA. Primers purchased from LifeTech
Laboratories were used to amplify the desired segments of cDNA. Applied BioSystem
TaqMan dye label for PCR per manufacturer’s recommendation. The amplification was
analyzed using a BioRad CFX Connect Real-Time PCR Detection System, and the Ct
values were normalized to gene expression of HPRT using the CT normalization
method.

Data Analysis
Data collected from BioRad DC protein assays was quantitatively analyzed to
establish a concentration curve using Microsoft Excel. Sigma Plot was utilized to
formulate each of the graphs used in this research study. At multiple points in the study,
unpaired t-tests were performed to determine the statistical significance of our collected
data. When the absence of a discernable numerical pattern was evident in both
preliminary data and Sigma Plot graphical analysis, the unpaired t-test was not utilized.
However, the unpaired t-test was utilized in all experiments that were of central
importance to the evaluation of our hypotheses. In this study, a p-value < 0.05 was
considered statistically significant.

RESULTS

We first conducted in vitro phosphorylation assays in order to examine total CaMKII
enzymatic activity in both young and aged mouse hippocampi. These in vitro
18

phosphorylation assays exhibited significantly decreased levels of CaMKII activity in the
hippocampi of aged mice (Figure 2). Once we found CaMKII activity to be significantly
diminished in the aged mouse hippocampus, we conducted other experiments in order to
identify the cause of the enzyme’s diminished activity. These experiments were
immunoblots and Real-Time PCR. Immunoblotting was performed using various
antibodies in order to enable us to attain a full picture of CaMKII protein expression in
both the young and aged mouse hippocampus. The first western blot experiment
performed used α-CaMKII (50 kDa) and GAPDH (40 kDA) antibodies as a means to
examine relative α-CaMKII expression. Levels of relative alpha CaMKII expression were
normalized to a value of one. The relative total CaMKII expression western blot yielded
no discernable pattern linking total CaMKII protein expression to diminished CaMKII
activity in the aged mouse hippocampus (Figure 3).
Like the first western blot, the second western blot also used an α-CaMKII antibody;
however, the samples used in this blot included both supernatants and pellets in order to
examine aggregation of total CaMKII. As mentioned previously, CaMKII is known to
aggregate at the self-association domain under ischemic conditions (Dosemeci 2000;
Tao-Cheng 2002; Hudmon 2005; Vest 2009). Aggregated CaMKII is unable to reactivate
when needed (Hudmon 1996). In the laboratory, we can assess aggregation by means of
differential centrifugation (Hudmon 1996). The α-CaMKII aggregation expression
western blot yielded no discernable pattern linking total CaMKII aggregation to
diminished CaMKII activity in the aged mouse hippocampus (Figure 4).
Next, we sought to examine the expression of the CaMKII inhibitor by way of
western blot using a CaMKN antibody. Sadly, the experiment did not yield quantifiable
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results. The gel image obtained from this western blot can be found in the supplemental
data section (Supplemental Figure 5).
As stated previously the constitutive activity of CaMKII is thought to play a critical
role in long-term potentiation. This constitutive activity occurs as a result of
autophosphorylation of Thr-286, which effectively blocks CaMKII’s autoregulatory
domain from binding to the p-site. We measured the expression of phosphorylated Thr286 CaMKII by means of the Cell Signaling Technology P-CaMKII (T286) rabbit
monoclonal antibody, which recognizes CaMKII phosphorylated at Thr-286.
Furthermore, we were able to quantify the relative expression of phosphorylated Thr-286
CaMKII by normalizing to total expression of α-CaMKII for each supernatant sample.
Quantification of the relative expression of phospho-CaMKII exhibited that expression of
phosphorylated Thr-286 CaMKII is significantly diminished in the aged mouse
hippocampus (Figure 5). From this result, we were able to identify a likely link between
diminished total CaMKII activity and diminished expression of phosphorylation of
CaMKII at Thr-286.
Having examined protein expression of CaMKII, we turned our attention to gene
expression. Real-Time PCR was used in order to examine gene expression of the
different CaMKII isoforms (α, β, γ, and δ) in young and aged mice. The results of the
PCR were normalized to HPRT. The Real-Time PCR conducted in this study yielded no
discernable pattern linking gene expression to diminished CaMKII activity in the aged
mouse hippocampus (Figure 6).
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Total CaMKII Activity

* = statistical
significance

Figure 2: Total CaMKII Activity: Phosphorylation assays revealed that total CaMKII
activity is diminished in the aged mouse hippocampus. Enzymatic activity was measured
using counts per minute per milligram of protein (cpms/mg). The diminished activity of
CaMKII in the aged mouse hippocampus was shown to be statistically significant (pvalue < 0.05 vs. young mice). Figure 2 provides a graphical quantification of the results
of the total CaMKII activity assay.
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Expression of Alpha CaMKII Protein

A

α-CaMKII

B

GAPDH

50
kDa

40
kDa

Figure 3: Relative Expression of the α-CaMKII Antibody: young and aged wild-type
mouse supernatant hippocampal protein samples were blotted with an α-CaMKII
antibody as well as an a GAPDH antibody. Levels of alpha CaMKII (α-CaMKII
antibody) expression were normalized to levels of GAPDH expression. A) a graphical
quantification of relative alpha CaMKII expression in young and aged wild-type mouse
supernatant hippocampal tissue samples. B) a representative images of western blots used
to quantify alpha-CaMKII expression in young and aged wild-type mouse supernatant
hippocampal tissue samples. See supplemental data section for a full Western blot images
(Supplemental Figure 1).
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Expression of Alpha CaMKII Aggregation

A

B

Figure 4: Expression of the α-CaMKII Antibody during Aggregation: young and
aged wild-type mouse pellet and supernatant hippocampal tissue samples were blotted
with a CaMKIIα antibody in order to quantify expression levels of CaMKIIα aggregation.
A) a graphical analysis of quantified levels of total CaMKII aggregation expression in
young and aged wild-type mouse pellet and supernatant hippocampal tissue samples. The
ratio used in this analysis was soluble to insoluble CaMKII (supernatant to pellet). B) a
representative image of a western blot gel used to quantify total CaMKII aggregation
expression. See supplemental data section for a full Western blot image (Supplemental
Figure 2).
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Expression of Phosphorylated Thr-286 CaMKII Protein

A

* = statistical
significance

P-CaMKII

α-CaMKII

50 kDa

B

Figure 5: Relative Expression of the P-CaMKII Antibody: young and aged wild-type
mouse supernatant hippocampal tissue samples were blotted with a p-CaMKII antibody
and an α-CaMKII antibody. Levels of phospho-CaMKII expression (p-CaMKII antibody)
were normalized to levels of total CaMKII expression (α-CaMKII antibody). A) a
graphical quantification of relative phospho-CaMKII expression in young and aged wildtype mouse supernatant hippocampal tissue samples (p-value = 0.03). B) representative
images of the western blot gel used to quantify relative phospho-CaMKII expression in
young and aged mouse supernatant samples. See supplemental data section for full
western blot images (Supplemental Figure 3).
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Gene Expression of the CaMKII Isoforms

A
Blue = Young
Green = Aged

Figure 6: Real-Time PCR of the CaMKII Isoforms: mouse hippocampal tissue
samples underwent real-time qPCR in order to analyze gene expression of the different
CaMKII isoforms. The major CaMKII isoforms are α, β, γ, and δ. The CT values were
normalized to gene expression of HPRT using the CT normalization method. A) a
graphical analysis of quantified gene expression levels of the CaMKII isoforms (α, β, γ,
and δ) in young and aged mouse hippocampal tissue samples.
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DISCUSSION

We hypothesized that when compared to young wild-type mouse hippocampi, aged
wild-type mouse hippocampi would have lower levels of total CaMKII activity, lower
levels of phosphorylated CaMKII expression, and higher levels of CaMKII inhibitor
expression. Activity assays, qPCR, protein quantification, and western blots were
conducted in order to test our hypotheses and to explore alternate explanations. The
results of the activity assay supported our hypothesis that total CaMKII phosphorylation
activity levels would be lower in aged mouse hippocampi than in young hippocampi.
Likewise, the results of our western blot analysis of relative phospho-CaMKII expression
supported our hypothesis that phospho-CaMKII expression would be diminished in the
aged wild-type mouse hippocampi. It is worth noting that the results of the relative
phospho-CaMKII western blot were significant having a p-value of 0.03 (p-value<0.05).
Our finding that phospho-CaMKII expression is significantly diminished in the aged
hippocampus suggests that dysfunction within the process of CaMKII phosphorylation at
Thr-286 contributes to the decline in total CaMKII activity. Furthermore, because of the
importance of Thr-286 autophosphorylation in the enzyme’s mediation of LTP induction,
it is plausible that diminished phosphorylation of CaMKII at Thr-286 contributed to the
learning and memory impairments exhibited by the aged mice in behavioral studies. As
was mentioned earlier, we were unsuccessful in our attempt to quantify expression of the
CaMKII inhibitor; it is unclear as to whether this result was due to human error or a
faulty antibody. The results of the qPCR did not exhibit that changes in gene expression
of the CaMKII isoforms occur in aged hippocampi. Similarly, the results of the relative
26

α-CaMKII western blot did not exhibit diminished expression of α-CaMKII in aged
hippocampi. Also, the results of the CaMKIIα aggregation western blot did not exhibit
that aggregation of α-CaMKII causes the decline in CaMKII activity in aged hippocampi.

FUTURE STUDIES

The impact of our findings lies in the illumination of the mechanisms causing
CaMKII activity to decline in the aged wild-type mouse hippocampus. In the future,
researchers should seek to build upon the link between decreased phosphorylated
CaMKII expression and decreased CaMKII activity. Likewise, researchers should
formulate strategies that increase CaMKII phosphorylation in order to alleviate learning
and memory problems in the aging brain. In terms of building upon the methods used in
this study, it would be beneficial to increase the number of animal subjects and to widen
the range of subject ages at time of euthanasia. Because of the fact that our CaMKII
inhibitor western blot was unsuccessful, this experiment should be repeated. Also, the
expression of the other CaMKII isoforms in advanced age should be evaluated. Lastly,
the effects of aging on other kinase proteins should be evaluated.
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Supplemental Figure 1

50 kDa
40 kDa

Supplemental Figure 1: complete images of a western blot used to quantify relative αCaMKII expression in young and aged wild-type mouse supernatant hippocampal tissue
samples. Expression of α-CaMKII (50 kDa) and GAPDH (40 kDa) were quantified then
used to determine relative α-CaMKII expression. In the first blot image, the blot was
incubated with an α-CaMKII primary antibody. In the second blot image, the blot was
incubated with a GAPDH primary antibody. Levels of relative alpha CaMKII expression
were normalized to a value of one. The ordering of samples of each image from left to
right is young-aged-young-aged etc.
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Supplemental Figure 2

50 kDa

Supplemental Figure 2: A complete image of a western blot used to quantify the
expression of total CaMKII (CaMKIIα) aggregation in both young and aged pellet and
supernatant hippocampal tissue samples. The ordering of samples in the image from left
to right is young-aged-young-aged etc.

Supplemental Figure 3

50 kDa

Supplemental Figure 3: complete images of western blots used to quantify the relative
expression of phospho-CaMKII in both young and aged supernatant hippocampal tissue
samples. The expression of p-CaMKII was normalized to α-CaMKII. In the first blot
image, the blot was incubated with an α-CaMKII primary antibody. In the second blot
image, the blot was incubated with a P-CaMKII primary antibody. The ordering of
samples of each image from left to right is young-aged-young-aged etc.
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Supplemental Figure 4

6.5 kDa

Supplemental Figure 4: A complete image of a western blot gel used to quantify the
expression of CaMKII inhibitor (CaMK-Nβ) (6.5 kDa) in both young and aged supernatant
hippocampal tissue samples. The ordering of samples in the image from left to right is
young-aged-young-aged etc.
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